Advances in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.

Semin Radiat Oncol 2017 07 20;27(3):247-255. Epub 2017 Feb 20.

Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Electronic address:

Stereotactic Body Radiation Therapy (SBRT) is an emerging effective treatment for hepatocellular carcinoma (HCC) associated with acceptable rates of toxicity in appropriately selected patients. Despite often being reserved for patients unsuitable for other local treatments, prospective and retrospective studies have demonstrated excellent long-term control. SBRT may be used as a stand-alone treatment, or as an adjunct to other HCC therapies. Based on available data, SBRT appears to complement existing local liver therapies. Randomized and nonrandomized comparative studies are required to better determine the optimal role of SBRT in HCC treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semradonc.2017.02.002DOI Listing
July 2017

Publication Analysis

Top Keywords

body radiation
8
radiation therapy
8
stereotactic body
8
hepatocellular carcinoma
8
stand-alone treatment
4
sbrt stand-alone
4
control sbrt
4
treatment adjunct
4
adjunct hcc
4
based data
4
therapies based
4
hcc therapies
4
long-term control
4
excellent long-term
4
reserved patients
4
local treatments
4
patients unsuitable
4
treatments prospective
4
retrospective studies
4
demonstrated excellent
4

Similar Publications